Full Text View
Tabular View
No Study Results Posted
Related Studies
A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)
This study has been completed.
Study NCT00051155   Information provided by Alcon Research
First Received: January 3, 2003   Last Updated: August 4, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Glaucoma, Open-Angle
Ocular Hypertension
Additional conditions recognized in this trial
Glaucoma
Hypertension
More general conditions related to this trial
Cardiovascular Diseases
Eye Diseases
Vascular Diseases
Interventions listed in this trial
Travoprost (0.004%)
Latanoprost (0.005%)/Timolol (0.5%)
Additional drug interventions recognized in this trial
Latanoprost
Travoprost
More general drug interventions related to this trial
Antihypertensive Agents
Cardiovascular Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Alcon Research


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services